SCOPUS 정보 검색 플랫폼

Volumn 84, Issue 3, 2001, Pages 313-320

A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

(7) Hartmann, J T a Vangerow, A von a Fels, L M b,c Knop, S a Stolte, H b,c Kanz, L a Bokemeyer, C a

a UNIVERSITY OF TÜBINGEN (Germany)

b HANNOVER MEDICAL SCHOOL (Germany)

c Soc for Sci and Technol Transfer (Germany)

Author keywords

Amifostine; Cytoprotection; High dose chemotherapy; PBSC transplantation; Pharmacoeconomics; Toxicity

Indexed keywords

AMIFOSTINE; CARBOPLATIN; DEXAMETHASONE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; OFLOXACIN; SEROTONIN 3 ANTAGONIST; TRIFLUPROMAZINE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BREAST CANCER; CELL PROTECTION; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION; MALE; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OVARY CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SARCOMA; STOMATITIS; TESTIS CANCER;

ADULT; AGED; AMIFOSTINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL DISEASES; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS; RADIATION-PROTECTIVE AGENTS; TREATMENT OUTCOME;

EID: 0035121911 PISSN: 00070920 EISSN: None Source Type: Journal
DOI: 10.1054/bjoc.2000.1611 Document Type: Article

Times cited : (42)

References (43)

1
- 8944220233
- A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
- (1996) N Engl J Med , vol.335 , pp. 91-97
- Attal, M.¹ Harousseau, J.L.² Stoppa, A.M.³ Sotto, J.J.⁴ Fuzibet, J.G.⁵ Rossi, J.F.⁶ Casassus, P.⁷ Maisonneuve, H.⁸ Facon, T.⁹ Ifrah, N.¹⁰ Payen, C.¹¹ Bataille, R.¹²

2
- 20244388258
- High dose chemotherapy and autologus bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours
- (1993) Br J Cancer , vol.68 , pp. 594-598
- Barnett, M.J.¹ Coppin, C.M.² Murray, N.³ Nevill, T.J.⁴ Reece, D.E.⁵ Klingemann, H.G.⁶ Shepherd, J.D.⁷ Nantel, S.H.⁸ Sutherland, H.J.⁹ Phillips, G.L.¹⁰

3
- 0028233047
- Economic analysis in phase III clinical cancer trials
- (1994) Cancer Invest , vol.12 , pp. 336-342
- Bennett, C.L.¹ Armitage, J.L.² Buchner, D.³ Galati, S.⁴

4
- 0033061781
- Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia
- (1999) Ann Oncol , vol.10 , pp. 177-182
- Bennett, C.L.¹ Stinson, T.J.² Tallman, M.S.³ Stadtmauer, E.A.⁴ Marsh, R.W.⁵ Friedenberg, W.⁶ Lazarus, H.M.⁷ Kaminer, L.⁸ Golub, R.M.⁹ Rowe, J.M.¹⁰

5
- 0030783771
- Nephrotoxicity after high dose carboplatin, etoposide and ifosfamide in germcell tumors: Incidence and implications for hematologic recovery and clinical outcome
- (1997) Bone Marrow Transplant , vol.20 , pp. 813-819
- Beyer, J.¹ Rick, O.² Weinknecht, S.³ Kingreen, D.⁴ Lenz, K.⁵ Siegert, W.⁶

6
- 0025981187
- High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors
- (1991) Bone Marrow Transplant , vol.7 , pp. 53-56
- Broun, E.R.¹ Nichols, C.R.² Tricot, G.³ Loehrer, P.J.⁴ Williams, S.D.⁵ Einhorn, L.H.⁶

7
- 0032993613
- Approaches to managing carboplatin induced thrombocytopenia: Focus on the role of amifostine
- (1999) Sere Oncol , vol.26 , Issue.SUPPL. 7 , pp. 41-50
- Budd, G.T.¹ Ganapathi, R.² Wood, L.³ Snyder, J.⁴ McLain, D.⁵ Bukowski, R.M.⁶

8
- 0024440650
- Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
- (1989) J Clin Oncol , vol.7 , pp. 1748-1756
- Calvert, A.H.¹ Newell, D.R.² Gumbrell, L.A.³ O'Reilly, S.⁴ Burnell, M.⁵ Boxall, F.E.⁶ Siddik, Z.H.⁷ Judson, I.R.⁸ Gore, M.E.⁹ Wiltshaw, E.¹⁰

9
- 0025339544
- A clinician's guide to cost effectiveness analysis
- (1990) Ann Intern Med , vol.113 , pp. 147-154
- Detsky, A.S.¹ Naglie, I.G.²

10
- 0024472914
- Clinical economics: A guide to the economic analysis of clinical practices
- (1989) JAMA , vol.262 , pp. 2879-2886
- Eisenberg, J.M.¹

11
- 0028960806
- Phase I study of high dose ifosfamide, carboplatin, etoposide with autologous hematopoietic stem cell support
- (1995) Bone Marrow Transplant , vol.15 , pp. 373-379
- Elias, A.D.¹ Ayash, L.J.² Wheeler, C.³ Schwartz, G.⁴ Tepler, I.⁵ Gonin, R.⁶ McCauley, M.⁷ Mazanet, R.⁸ Schnipper, L.⁹ Frei, E.¹⁰

12
- 4243517720
- Amifostine with high dose ifosfamide, carboplatin, and etoposide with hematopoietic stem cell support
- abstr. 197
- (2000) Proc Am Soc Clin Oncol , vol.19
- Elias, A.¹ Richardsen, P.² Tretyakov, O.³ Avigan, A.⁴ Warren, D.⁵ Arthur, T.⁶ McCauley, M.⁷ Wright, J.⁸ Frei, E.⁹

13
- 0030810515
- Generalisation from phase III clinical trials: Survival, quality of life, and health economics
- (1999) Lancet , vol.350 , pp. 1025-1027
- Fayers, P.M.¹ Hand, D.J.²

14
- 0033053286
- Standard and high dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small cell lung cancer: A mature follow up report
- (1999) Ann Oncol , vol.10 , pp. 561-567
- Fetscher, S.¹ Brugger, W.² Engelhardt, R.³ Kanz, L.⁴ Hasse, J.⁵ Frommhold, H.⁶ Lange, W.⁷ Mertelsmann, R.⁸

15
- 0028847797
- Maximum tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem cell rescue: Toxicity profile
- (1995) J Clin Oncol , vol.13 , pp. 323-332
- Fields, K.K.¹ Elfenbein, G.J.² Lazarus, H.M.³ Cooper, B.W.⁴ Perkins, J.B.⁵ Creger, R.J.⁶ Ballester, O.F.⁷ Hiemenz, J.H.⁸ Janssen, W.E.⁹ Zorsky, P.E.¹⁰

16
- 0032887664
- Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer
- (1999) J Clin Oncol , vol.17 , pp. 3038-3047
- Gelmon, K.¹ Eisenhauer, E.² Bryce, C.³ Tolcher, A.⁴ Mayer, L.⁵ Tomlinson, E.⁶ Zee, B.⁷ Blackstein, M.⁸ Tomiak, E.⁹ Yau, J.¹⁰ Batist, G.¹¹ Fisher, B.¹² Iglesias, J.¹³

17
- 0030973746
- High dose chemotherapy and autologous bone marrow transplantation compared with MACOP B in aggressive B cell lymphoma
- (1997) N Engl J Med , vol.336 , pp. 1290-1297
- Gianni, A.M.¹ Bregni, M.² Siena, S.³ Brambilla, C.⁴ DiNicola, M.⁵ Lombardi, F.⁶ Gandola, L.⁷ Tarella, C.⁸ Pileri, A.⁹ Ravagnani, F.¹⁰ Valagussa, P.¹¹ Bonadonna, G.¹² Stern, A.C.¹³ Magni, M.¹⁴ Caracciolo, D.¹⁵

18
- 0031004064
- Efficacy, toxicity, and applicability of high dose sequential chemotherapy as adjuvant treatment in operable breaset cancer with 10 or more involved axillary nodes: Five year results
- (1997) J Clin Oncol , vol.15 , pp. 2312-2321
- Gianni, A.M.¹ Siena, S.² Bregni, M.³ DiNicola, M.⁴ Orefice, S.⁵ Cusumano, F.⁶ Salvadori, B.⁷ Luini, A.⁸ Greco, M.⁹ Zucali, R.¹⁰ Rilke, E.¹¹ Zambetti, M.¹² Valagussa, P.¹³ Bonadonna, G.¹⁴

19
- 0012485416
- Use of pharmacoeconomic data by regulatory authorities
- Quality of life and pharmacoeconomics in clinical trials, Spiker B (ed). Lippinciott-Raven: Philadelphia, PA
- (1996) , pp. 1141-1147
- Glasziou, P.P.¹ Mitchell, A.S.²

20
- 0022655609
- WR 2721 protects against the hematologic toxicity of cyclophosphamide: A controlled phase II trial
- (1986) J Clin Oncol , vol.4 , pp. 584-588
- Glover, D.¹ Glick, J.H.² Weiler, C.³ Hurowitz, S.⁴ Kligerman, M.M.⁵

21
- 0023140888
- Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna
- (1987) Cancer Treat Rep , vol.71 , pp. 127-130
- Goren, M.P.¹ Wright, R.K.² Horowitz, M.E.³ Pratt, C.B.⁴

22
- 0031056945
- Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor risk aggressive non Hodgkin's lymphoma: Updated results of the prospective study LNH87 2
- (1997) J Clin Oncol , vol.15 , pp. 1131-1137
- Haioun, C.¹ Lepage, E.² Gisselbrecht, C.³ Bastion, Y.⁴ Coiffier, B.⁵ Brice, P.⁶ Bosly, A.⁷ Dupriez, B.⁸ Nouvel, C.⁹ Tilly, H.¹⁰ Lederlin, P.¹¹ Biron, P.¹² Briere, J.¹³ Gaulard, P.¹⁴ Reyes, F.¹⁵

23
- 0032815295
- Diagnosis and treatment of patients with testicular germ cell cancer
- (1999) Drugs , vol.58 , pp. 257-281
- Hartmann, J.T.¹ Kanz, L.² Bokemeyer, C.³

24
- 0032707984
- Platinum organ toxicity and its possible prevention in patients with testicular cancer
- (1999) Int J Cancer , vol.83 , pp. 866-869
- Hartmann, J.T.¹ Kollmannsberger, C.² Kanz, L.³ Bokemeyer, C.⁴

25
- 0034023715
- The use of reduced doses of amifostine to ameloriate nephrotoxicity of cisplalin/ifosfamide-based chemotherapy in patients with solid tumors
- (2000) Anti-Cancer Drugs , vol.11 , pp. 1-6
- Hartmann, J.T.¹ Knop, S.² Fels, L.M.³ Van Vangerow, A.⁴ Stolte, H.⁵ Kanz, L.⁶ Bokemeyer, C.⁷

26
- 0033887458
- A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors
- (2000) Invest New Drugs , vol.18 , pp. 281-289
- Hartmann, J.T.¹ Fels, L.M.² Knop, S.³ Stolte, H.⁴ Kanz, L.⁵ Bokemeyer, C.⁶

27
- 0034529165
- Evaluation of the acute nephrotoxicity of cisplatin- and high dose carboplatin based combination chemotherapy
- (2000) Anticancer Research , vol.20 , pp. 3767-3774
- Hartmann, J.T.¹ Fels, L.M.² Franzke, A.³ Knop, S.⁴ Renn, M.⁵ Maeß, B.⁶ Panagiotou, P.⁷ Lampe, H.⁸ Kanz, L.⁹ Stolte, H.¹⁰ Bokemeyer, C.¹¹

28
- 0029902007
- Amifostine pretreatment for protection against cyclophosphamide induced and cisplatin induced toxicities: Results of a randomized control trial in patients with advanced ovarian cancer
- (1996) J Clin Oncol , vol.14 , pp. 2101-2112
- Kemp, G.¹ Rose, P.² Lurain, J.³ Berman, M.⁴ Manetta, A.⁵ Roullet, B.⁶ Homesley, H.⁷ Belpomme, D.⁸ Glick, J.⁹

29
- 0027404777
- Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNL1 randomized trial
- (1993) Lancet , vol.341 , pp. 1051-1054
- Linch, D.C.¹ Winfield, D.² Goldstone, A.H.³ Moir, D.⁴ Hancock, B.⁵ McMillan, A.⁶ Chopra, R.⁷ Milligan, D.⁸ Hudson, G.V.⁹

30
- 10144242638
- Treatment of germ cell cancer with two cycles of high dose ifosfamide, carboplatin, and etoposide with autologous stem cell support
- (1996) J Clin Oncol , vol.14 , pp. 2631-2637
- Margolin, K.¹ Doroshow, J.H.² Ahn, C.³ Hamasaki, V.⁴ Leong, L.⁵ Morgan, R.⁶ Raschko, J.⁷ Shibata, S.⁸ Somlo, G.⁹ Tetef, M.¹⁰

31
- 0028790440
- Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non Hodgkin's lymphoma
- (1995) N Engl J Med , vol.333 , pp. 1540-1545
- Philip, T.¹ Guglielmi, C.² Hagenbeek, A.³ Somers, R.⁴ Van der Lelie, H.⁵ Bran, D.⁶ Sonneveld, P.⁷ Gisselbrecht, C.⁸ Cahn, J.Y.⁹ Harousseau, J.L.¹⁰ Coiffier, B.¹¹ Biron, P.¹² Mandelli, F.¹³ Chauvin, F.¹⁴

32
- 0032887240
- Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support
- (1999) J Clin Oncol , vol.17 , pp. 3064-3074
- Rizzieri, D.A.¹ Vredenburgh, J.J.² Jones, R.³ Ross, M.⁴ Shpall, E.J.⁵ Hussein, A.⁶ Broadwater, G.⁷ Berry, D.⁸ Petros, W.P.⁹ Gilbert, C.¹⁰ Affronti, M.L.¹¹ Coniglio, D.¹² Rubin, P.¹³ Elkordy, M.¹⁴ Long, G.D.¹⁵ Chao, N.J.¹⁶ Peters, W.P.¹⁷

33
- 0026676264
- High dose chemotherapy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: A phase two study
- (1992) Ann Oncol , vol.3 , pp. 809-812
- Rosti, G.¹ Albertazzi, L.² Salvioni, R.³ Pizzocaro, G.⁴ Cetto, G.L.⁵ Bassetto, M.A.⁶ Marangolo, M.⁷

34
- 0029782690
- The role of cost effectiveness analysis in health and medicine
- (1996) JAMA , vol.276 , pp. 1172-1177
- Russell, L.B.¹ Gold, M.R.² Siegel, J.E.³ Daniels, N.⁴ Weinstein, M.C.⁵

35
- 0030755761
- Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors
- (1997) J Clin Oncol , vol.15 , pp. 2981-2995
- Savarese, D.E.M.¹ Hsieh, C.² Stewart, F.M.³

36
- 0028229053
- High dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study
- The German Testicular Cancer Cooperative Study Arm
- (1994) J Clin Oncol , vol.12 , pp. 1223-1231
- Siegert, W.¹ Beyer, J.² Strohscheer, I.³ Baurmann, H.⁴ Oettle, H.⁵ Zingsem, J.⁶ Zimmermann, R.⁷ Bokemeyer, C.⁸ Schmoll, H.J.⁹ Huhn, D.¹⁰

37
- 0027517584
- WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: A molecular approach
- (1993) Cancer Chemother Pharmacol , vol.33 , pp. 93-106
- Treskes, M.¹ Van der Vijgh, W.²

38
- 0032481412
- Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: High dose versus standard dose chemotherapy
- (1998) J Natl Cancer Inst , vol.90 , pp. 210-218
- Van Dam, F.S.A.M.¹ Schagen, S.B.² Muller, M.J.³ Boogerd, W.⁴ Von der Wall, E.⁵ Fortuyn, M.E.D.⁶ Rodenhuis, S.⁷

39
- 0027281672
- Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy
- The New York Gynecologic Oncology Group
- (1993) J Clin Oncol , vol.11 , pp. 1517-1522
- Wadler, S.¹ Haynes, H.² Beitler, J.J.³ Goldberg, G.⁴ Holland, J.F.⁵ Hochster, H.⁶ Bruckner, H.⁷ Mandeli, J.⁸ Smith, H.⁹ Runowicz, C.¹⁰

40
- 0024843812
- Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer
- (1989) Drugs , vol.37 , pp. 162-190
- Wagstaff, A.J.¹ Ward, A.² Benfield, P.³ Heel, R.C.⁴

41
- 0027103082
- Phase I and II study of high dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors
- (1992) J Clin Oncol , vol.10 , pp. 1712-1722
- Wilson, W.H.¹ Jain, V.² Bryant, G.³ Cowan, K.H.⁴ Carter, C.⁵ Cottler Fox, M.⁶ Goldspiel, B.⁷ Steinberg, S.M.⁸ Longo, D.L.⁹ Wittes, R.E.¹⁰

42
- 0029010195
- High dose ifosfamide, carboplatin, and etoposide pharmacokinetics: Correlation of plasma drug levels with renal toxicity
- (1995) Cancer Chemother Pharmacol , vol.36 , Issue.4 , pp. 345-351
- Wright, J.E.¹ Elias, A.² Tretyakov, O.³ Holden, S.⁴ Andersen, J.⁵ Wheeler, C.⁶ Schwartz, G.⁷ Antman, K.⁸ Rosowsky, A.⁹ Frei, E.¹⁰

43
- 0028889993
- Autologous or allogeneic bone marrow tranplantation compared with intensive chemotheraphy in acute myelogenous leukemia
- European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia co-opearative Arms
- (1995) N Engl J Med , vol.332 , pp. 217-223
- Zittoun, R.A.¹ Mandelli, F.² Willemze, R.³ De Witte, T.⁴ Labar, B.⁵ Resegotti, L.⁶ Leoni, F.⁷ Damasio, E.⁸ Visani, G.⁹ Papa, G.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.